SCHEMBL6967393

SCHEMBL6967393

CCCCOc1ccc(C(=O)c2c(-c3ccc(OC)cc3)sc3cc(OC)ccc23)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 17/20 0.71
ESR2 Q92731 10/20 0.71
TUBB4A P04350 1/20 0.64
TUBB P07437 1/20 0.64
TUBA3C P0DPH7 1/20 0.64
TUBA1B P68363 1/20 0.64
TUBA4A P68366 1/20 0.64
TUBB4B P68371 1/20 0.64
TUBB3 Q13509 1/20 0.64
TUBB2A Q13885 1/20 0.64
TUBB8 Q3ZCM7 1/20 0.64
TUBA3E Q6PEY2 1/20 0.64
TUBA1A Q71U36 1/20 0.64
TUBA1C Q9BQE3 1/20 0.64
TUBB6 Q9BUF5 1/20 0.64
TUBB2B Q9BVA1 1/20 0.64
TUBB1 Q9H4B7 1/20 0.64
CNR1 P21554 1/20 0.63
CNR2 P34972 1/20 0.63
ENPP3 O14638 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6973749 0.97 ESR1 (0.68) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL6980679 0.95 ESR1 (0.71) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL11552962 0.93 ESR1 (0.72) ESR1ESR2CNR1
SCHEMBL7970907 0.92 ESR1 (0.73) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL16380497 0.91 ESR1 (0.67) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL11547336 0.91 ESR1 (0.61) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL7671512 0.91 ESR1 (0.69) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL7665777 0.91 ESR1 (0.69) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL6425122 0.91 ESR1 (0.68) ESR1ESR2TUBB4ATUBBTUBA3C
SCHEMBL7667665 0.90 ESR1 (0.68) ESR1ESR2TUBB4ATUBBTUBA3C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0766559-B1 CANNABINOID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 2003-11-19 EP disclosed
EP-0832888-B1 Benzothiophene compounds, compositions, and methods LILLY CO ELI (US) 2003-07-23 EP disclosed
US-5981570-A INHIBITING BONE LOSS OR BONE RESORPTION, PARTICULARLY OSTEOPOROSIS, CARDIOVASCULAR-RELATED PATHOLOGICAL CONDITIONS, INCLUDING HYPERLIPIDEMIA. ELI LILLY AND COMPANY (US) 1999-11-09 US disclosed
EP-0766559-A4 CANNABINOID RECEPTOR ANTAGONISTS LILLY CO ELI (US) 1997-08-06 EP disclosed
EP-0766559-A1 CANNABINOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1997-04-09 EP disclosed
US-5596106-A ARYL-BENZO(B)THIOPHENE OR BENZO(B)FURAN COMPOUNDS ELI LILLY AND COMPANY (US) 1997-01-21 US disclosed
WO-1996002248-A1 CANNABINOID RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 1996-02-01 WO disclosed